Dr. Reddy’s recalls 1k cancer drug vials over container defect: 4 things to know

Dr. Reddy’s Laboratories on Jan. 9 recalled 1,051 vials of the cancer drug Docetaxel, according to the FDA’s enforcement report for the week of Jan. 17.

Advertisement

Here are four things to know.

1. Docetaxel is a chemotherapy drug used to treat various cancers, including breast, lung, prostate and stomach cancer.

2. Dr. Reddy’s recalled the drug after receiving reports of a defect in the injection vials’ aluminum seal.

3. The drugmaker distributed the affected product nationwide in the U.S., Uzbekistan and Myanmar.

4. Dr. Reddy’s is notifying customers of the recall, which is ongoing, via letters.

More articles on supply chain:
Mylan reaffirms $1B share buyback plan
FDA: IV fluid shortage exacerbated by hurricane damage to Puerto Rico is expected to improve
Stanford Blood Center faces critical shortage of blood, notes the flu is keeping potential donors away

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.